Antiviral Activity, Safety, and Tolerability of Multiple Ascending Doses of Elbasvir or Grazoprevir in Participants Infected With Hepatitis C Virus Genotype-1 or -3

Autor:	Yeh, Wendy W., Fraser, Iain P., Jumes, Patricia, Petry, Amelia, Lepeleire, Inge De, Robberechts, Martine, Reitmann, Christina, Van Dyck, Kristien, Huang, Xiaobi, Guo, Zifang, Panebianco, Deborah, Nachbar, Robert B., O’Mara, Edward, Wagner, John A., Butterton, Joan R., Dutko, Frank J., Moiseev, Valentin, Kobalava, Zhanna, Hüser, Andreas, Visan, Sorin, Schwabe, Christian, Gane, Edward, Popa, Serghei, Ghicavii, Nelea, Uhle, Markus, Wagner, Frank
Zdroj:	In Clinical Therapeutics May 2018 40(5):704-718
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect